Paul Brady
Overview
Explore the profile of Paul Brady including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurunathan U, Medcalf R, Chiang L, Liu Z, Liu X, Keragala C, et al.
Br J Anaesth
. 2025 Jan;
PMID: 39848872
Background: Uncertainty about optimal tranexamic acid (TXA) dosage has led to significant practice variation in hip arthroplasty. We aimed to identify the optimal i.v. dosage of TXA using a population...
2.
Desai S, Natarajan B, Khanna V, Brady P
CVIR Endovasc
. 2024 Apr;
7(1):39.
PMID: 38642226
Purpose: To evaluate the efficacy and safety of hepatic artery interventions (HAI) versus extra-hepatic arterial interventions (EHAI) when managing clinically significant hepatic artery stenosis (HAS) after adult orthotopic liver transplantation....
3.
Varelas P, Kananeh M, Brady P, Holden D, Mehta C, Ata A, et al.
Crit Care Med
. 2023 Nov;
52(2):e58-e66.
PMID: 37966309
Objectives: Systematic reviews have revealed that up to 50% of patients with brain death have residual hypothalamic/pituitary activity based on the absence of central diabetes insipidus (DI). We hypothesized that...
4.
Chua W, Cardoso V, Guasch E, Sinner M, Al-Taie C, Brady P, et al.
Sci Rep
. 2023 Oct;
13(1):16743.
PMID: 37798357
Early detection of atrial fibrillation (AF) enables initiation of anticoagulation and early rhythm control therapy to reduce stroke, cardiovascular death, and heart failure. In a cross-sectional, observational study, we aimed...
5.
Reinert J, Brady P
J Pharm Technol
. 2023 Sep;
39(5):237-240.
PMID: 37745730
Acute encephalopathy is a common symptom encountered in critically ill patients and may be associated with Wernicke's encephalopathy (WE) or serotonin syndrome (SS). We describe a patient who presented with...
6.
Alenazy F, Harbi M, Kavanagh D, Price J, Brady P, Hargreaves O, et al.
J Thromb Haemost
. 2023 Aug;
21(11):3236-3251.
PMID: 37541591
Background: Aspirin and platelet P2Y inhibitors, such as ticagrelor, suboptimally inhibit microvascular thrombosis during ST-elevation myocardial infarction. Glycoprotein (GP) IIb/IIIa inhibitors may further inhibit this but cause excessive bleeding. Objectives:...
7.
Kormanyos Z, Reinert J, Brady P
Expert Rev Clin Pharmacol
. 2022 Nov;
15(12):1415-1421.
PMID: 36377793
Introduction: Patients who have experienced an aneurysmal subarachnoid hemorrhage (aSAH) may face a significant morbidity burden following the acute phase of their injury. Though commonly employed as an anticoagulant, heparin...
8.
Hilal L, Cercek A, Navilio J, Hsu M, Zhang Z, Brady P, et al.
Adv Radiat Oncol
. 2022 Jan;
7(1):100801.
PMID: 35071829
Purpose: Pelvic radiation therapy (RT) is standard of care for patients with locally advanced rectal cancer (LARC). Premature ovarian insufficiency (POI) in premenopausal women is a possible side effect. The...
9.
Hilal L, Reyngold M, Wu A, Araji A, Abou-Alfa G, Jarnagin W, et al.
J Gastrointest Oncol
. 2021 Sep;
12(4):1743-1752.
PMID: 34532124
Background: More than 70% of patients with hepatocellular carcinoma (HCC) are not candidates for curative therapy or recur after curative-intent therapy. There is growing evidence on the use of ablative...
10.
Phillips K, Subramanian A, Neil Thomas G, Khan N, Chandan J, Brady P, et al.
Heart
. 2021 Jul;
108(7):517-522.
PMID: 34226195
Objective: The pharmacological management of atrial fibrillation (AF) comprises anticoagulation, for stroke prophylaxis, and rate or rhythm control drugs to alleviate symptoms and prevent heart failure. The aim of this...